Pharmacogenetically driven patient selection for a first-in-human phase I trial of batracylin in patients with advanced solid tumors and lymphomas

Author: Kummar Shivaani   Gutierrez Martin   Anderson Lawrence   Klecker Raymond   Chen Alice   Murgo Anthony   Doroshow James   Collins Jerry  

Publisher: Springer Publishing Company

ISSN: 0344-5704

Source: Cancer Chemotherapy and Pharmacology, Vol.72, Iss.4, 2013-10, pp. : 917-923

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content